REG - Duke Royalty Limited - Director/PDMR Shareholding

Duke CapitalAnnouncement

15/07/2020 07:00

RNS Number : 0091T
  
Duke Royalty Limited
  
15 July 2020
  
 

15 July 2020
 
Duke Royalty Limited
("Duke Royalty", "Duke" or the "Company")
Director/PDMR Dealings  
 
The Company announces that certain directors [and persons discharging managerial responsibilities (PDMRs)] and their persons closely associated (PCAs) have acquired new ordinary shares in the Company ("Scrip Shares") pursuant to the recent scrip dividend, as follows.
 



Director/PDMR


No. of Scrip Shares acquired


Total resultant number of ordinary shares held in the Company




Neil Johnson 


68,997


3,718,997




Charlie Cannon Brookes


54,820


2,954,820




Arlington Asset Management*


50,221


2,706,914




Nigel Birrell


15,964


860,464




Matthew Wrigley


510


27,510




Justin Cochrane


15,405


830,405



 
*Arlington Group Asset Management Limited is a person closely associated with Charlie Cannon Brookes
 
The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
 
 



1 
 


Details of the person discharging managerial responsibilities / person closely associated 
 




a) 
 


Name 
 


Neil Johnson




2 
 


Reason for the notification 
 




a) 
 


Position/status 


Chief Executive Officer




b) 
 


Initial notification /Amendment 


Initial




3 
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 
 




a) 
 


Name 
 


Duke Royalty Limited




b) 
 


LEI 


213800GUTKPSJ39SER44




4 
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 
 




a) 
 


Description of the financial instrument, type of instrument 
 
Identification code
 
 


 
Ordinary shares of nil par value 
 
ISIN: GG00BYZSSY63
 
 
 




b) 
 


Nature of the transaction 


Acquisition of shares pursuant to scrip dividend




c) 
 


Price(s) and volume(s) 
 


 



Price(s)
 


Volume(s)




 
Scrip reference price of 26.45p per share
 


 
68,997








d) 
 


Aggregated information 
 
- Aggregated volume 
 
- Price 


 
 
N/A 
 
 
 




e) 
 


Date of the transaction 
 


10 July 2020




f) 
 


Place of the transaction 
 


London Stock Exchange



 
 



1 
 


Details of the person discharging managerial responsibilities / person closely associated 
 




a) 
 


Name 
 


Charlie Cannon Brookes




2 
 


Reason for the notification 
 




a) 
 


Position/status 


Executive Director




b) 
 


Initial notification /Amendment 


Initial




3 
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 
 




a) 
 


Name 
 


Duke Royalty Limited




b) 
 


LEI 


213800GUTKPSJ39SER44




4 
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 
 




a) 
 


Description of the financial instrument, type of instrument 
 
Identification code
 
 


 
Ordinary shares of nil par value 
 
ISIN: GG00BYZSSY63
 
 
 




b) 
 


Nature of the transaction 


Acquisition of shares pursuant to scrip dividend




c) 
 


Price(s) and volume(s) 
 


 



Price(s)
 


Volume(s)




 
Scrip reference price of 26.45p per share
 


 
54,820








d) 
 


Aggregated information 
 
- Aggregated volume 
 
- Price 


 
 
N/A 
 
 
 




e) 
 


Date of the transaction 
 


10 July 2020




f) 
 


Place of the transaction 
 


London Stock Exchange



 



1 
 


Details of the person discharging managerial responsibilities / person closely associated 
 




a) 
 


Name 
 


Arlington Group Asset Management Limited




2 
 


Reason for the notification 
 




a) 
 


Position/status 


Person closely associated with Charlie Cannon Brookes, Executive Director of Duke Royalty Limited
 




b) 
 


Initial notification /Amendment 


Initial




3 
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 
 




a) 
 


Name 
 


Duke Royalty Limited




b) 
 


LEI 


213800GUTKPSJ39SER44




4 
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 
 




a) 
 


Description of the financial instrument, type of instrument 
 
Identification code
 
 


 
Ordinary shares of nil par value 
 
ISIN: GG00BYZSSY63
 
 
 




b) 
 


Nature of the transaction 


Acquisition of shares pursuant to scrip dividend




c) 
 


Price(s) and volume(s) 
 


 



Price(s)
 


Volume(s)




 
Scrip reference price of 26.45p per share
 


 
50,221








d) 
 


Aggregated information 
 
- Aggregated volume 
 
- Price 


 
 
N/A 
 
 
 




e) 
 


Date of the transaction 
 


10 July 2020




f) 
 


Place of the transaction 
 


London Stock Exchange



 



1 
 


Details of the person discharging managerial responsibilities / person closely associated 
 




a) 
 


Name 
 


Nigel Birrell




2 
 


Reason for the notification 
 




a) 
 


Position/status 


Chairman
 




b) 
 


Initial notification /Amendment 


Initial




3 
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 
 




a) 
 


Name 
 


Duke Royalty Limited




b) 
 


LEI 


213800GUTKPSJ39SER44




4 
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 
 




a) 
 


Description of the financial instrument, type of instrument 
 
Identification code
 
 


 
Ordinary shares of nil par value 
 
ISIN: GG00BYZSSY63
 
 
 




b) 
 


Nature of the transaction 


Acquisition of shares pursuant to scrip dividend




c) 
 


Price(s) and volume(s) 
 


 



Price(s)
 


Volume(s)




 
Scrip reference price of 26.45p per share
 


 
15,964








d) 
 


Aggregated information 
 
- Aggregated volume 
 
- Price 


 
 
N/A 
 
 
 




e) 
 


Date of the transaction 
 


10 July 2020




f) 
 


Place of the transaction 
 


London Stock Exchange



 



1 
 


Details of the person discharging managerial responsibilities / person closely associated 
 




a) 
 


Name 
 


Matthew Wrigley




2 
 


Reason for the notification 
 




a) 
 


Position/status 


Director
 




b) 
 


Initial notification /Amendment 


Initial




3 
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 
 




a) 
 


Name 
 


Duke Royalty Limited




b) 
 


LEI 


213800GUTKPSJ39SER44




4 
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 
 




a) 
 


Description of the financial instrument, type of instrument 
 
Identification code
 
 


 
Ordinary shares of nil par value 
 
ISIN: GG00BYZSSY63
 
 
 




b) 
 


Nature of the transaction 


Acquisition of shares pursuant to scrip dividend




c) 
 


Price(s) and volume(s) 
 


 



Price(s)
 


Volume(s)




 
Scrip reference price of 26.45p per share
 


 
510








d) 
 


Aggregated information 
 
- Aggregated volume 
 
- Price 


 
 
N/A 
 
 
 




e) 
 


Date of the transaction 
 


10 July 2020




f) 
 


Place of the transaction 
 


London Stock Exchange



 



1 
 


Details of the person discharging managerial responsibilities / person closely associated 
 




a) 
 


Name 
 


Justin Cochrane




2 
 


Reason for the notification 
 




a) 
 


Position/status 


PDMR
 




b) 
 


Initial notification /Amendment 


Initial




3 
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 
 




a) 
 


Name 
 


Duke Royalty Limited




b) 
 


LEI 


213800GUTKPSJ39SER44




4 
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 
 




a) 
 


Description of the financial instrument, type of instrument 
 
Identification code
 
 


 
Ordinary shares of nil par value 
 
ISIN: GG00BYZSSY63
 
 
 




b) 
 


Nature of the transaction 


Acquisition of shares pursuant to scrip dividend




c) 
 


Price(s) and volume(s) 
 


 



Price(s)
 


Volume(s)




 
Scrip reference price of 26.45p per share
 


 
15,405








d) 
 


Aggregated information 
 
- Aggregated volume 
 
- Price 


 
 
N/A 
 
 
 




e) 
 


Date of the transaction 
 


10 July 2020




f) 
 


Place of the transaction 
 


London Stock Exchange



 
 
 
***ENDS***
 
For further information, please contact www.dukeroyalty.com, or contact:
 



Duke Royalty Limited


Neil Johnson / Charlie Cannon Brookes / Hugo Evans
 


+44 (0) 1481 741 240




Cenkos Securities plc 
(Nominated Adviser and Broker)
 


Stephen Keys / Callum Davidson / Julian Morse / Michael Johnson
 


+44 (0) 207 397 8900




Newgate Communications (PR)


Elisabeth Cowell/ Ian Silvera/ Megan Kovach


+ +44 (0) 20 3757 6880 dukeroyalty@newgatecomms.com
 



 
About Duke Royalty
 
Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.
 
 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
DSHBIGDRUSBDGGS